Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Has your treatment of menopausal women changed since the initial findings released from the Women's Health Initiative (WHI) randomized, controlled trials of hormone therapy (HT)? Findings from a just-published secondary analysis of data from the WHI indicate that women who initiated HT closer to menopause tended to have reduced risk of coronary heart disease (CHD), while women further from menopause tended to have a slightly higher risk for the disease.

New data emerge from the WHI: How will they impact your practice?